AllQuantitative Report
Argus•December 30, 2020
Argus•December 30, 2020RMD: What does Argus have to say about RMD?
Symbols
RMDSector(s)
Healthcare
Rating
Premium
Current Price
$214.50
Price Target
$NaN
Earnings Estimate
Premium
Summary
ResMed is one of the largest global respiratory medical devices companies, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea.
Premium
Subscribe to Yahoo Finance Premium for full access
Read the latest independent research including analyst forecasts, ratings on the US economy, and more. Get individual company and overall sector level recommendations.
Try Premium FREEActions
Download Full ReportRelated Reports
- STE: Lowering target price to $198.00Jan 20, 2021 •
STE
- VAR: What does Argus have to say about VAR?Jan 20, 2021 •
VAR
- COO: Raising target price to $409.00Jan 20, 2021 •
COO
- TFX: Lowering target price to $403.00Jan 20, 2021 •
TFX
- Analyst Report: STERIS plcJan 15, 2021 •
STE
© 2021 Verizon Media. All rights reserved.
